SeaStar Medical Holding Corporation reported positive preliminary results from the SAVE Surveillance Registry, which evaluates the QUELIMMUNE therapy for critically ill pediatric patients suffering ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results